CLSD - Clearside Biomedical, Inc.
0.41
-0.151 -36.902%
Share volume: 2,599,533
Last Updated: 11-28-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.56
-0.15
-0.27%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 05-15-2025 | 08-08-2025 | 11-14-2025 | |
| Assets | ||||||||
| Total Assets | 40.142 M | 33.934 M | 29.161 M | 25.126 M | 19.668 M | 15.332 M | 11.641 M | |
| Current Assets | 36.115 M | 29.768 M | 25.113 M | 21.274 M | 15.964 M | 11.785 M | 8.254 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 193.000 K | 44.000 K | 13.000 K | 13.000 K | 77.000 K | 13.000 K | 0.000 | |
| Short Term Investments | 0.000 | 11.122 M | 9.703 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 35.355 M | 18.238 M | 13.888 M | 20.020 M | 13.628 M | 9.376 M | 6.801 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.194 M | 3.400 M | 3.351 M | 3.225 M | 3.149 M | 3.065 M | 2.981 M | |
| Other Assets | 833.000 K | 766.000 K | 697.000 K | 627.000 K | 555.000 K | 482.000 K | 406.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 40.142 M | 33.934 M | 29.161 M | 25.126 M | 19.668 M | 15.332 M | 11.641 M | |
| Total liabilities | 61.952 M | 62.219 M | 63.950 M | 63.981 M | 65.578 M | 64.066 M | 65.591 M | |
| Total current liabilities | 5.950 M | 5.874 M | 5.593 M | 4.794 M | 5.012 M | 3.047 M | 2.770 M | |
| Accounts Payable | 1.363 M | 1.576 M | 2.361 M | 1.452 M | 1.914 M | 1.129 M | 796.000 K | |
| Other liabilities | 56.002 M | 56.345 M | 58.357 M | 59.187 M | 60.566 M | 61.019 M | 62.821 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 56.002 M | 56.345 M | 58.357 M | 59.187 M | 60.566 M | 61.019 M | 62.821 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -21.810 M | -28.285 M | -34.789 M | -38.855 M | -45.910 M | -48.734 M | -53.950 M | |
| Common stock | 310.876 M | 311.996 M | 313.175 M | 316.420 M | 317.588 M | 319.259 M | 320.015 M | |
| Retained earnings | -332.686 M | -340.280 M | -347.969 M | -355.275 M | -363.498 M | -367.993 M | -373.965 M |